Charles L. Sawyers
In 2011 Charles L. Sawyers was named a Thomson Reuters Citation Laureate in Medicine with Brian J. Druker and Nicholas B. Lydon Charles L. Sawyers for their development of imatinib and dasatinib, revolutionary, targeted treatments for chronic myeloid leukemia. Below are more details.
- Role: Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis, Memorial Sloan-Kettering Cancer Center, New York, NY USA. Also, Howard Hughes Medical Institute Investigator